Cyclo Therapeutics Receives Grant Notice From European Patent Office For Patent On Methods For Treating Alzheimer's Disease; European Patent Number 3873604B To Be Published On August 21, 2024
Portfolio Pulse from Benzinga Newsdesk
Cyclo Therapeutics has received a grant notice from the European Patent Office for a patent on methods for treating Alzheimer's Disease. The European Patent Number 3873604B will be published on August 21, 2024.
July 29, 2024 | 1:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cyclo Therapeutics has received a grant notice from the European Patent Office for a patent on methods for treating Alzheimer's Disease. The patent will be published on August 21, 2024.
The grant notice for a patent on Alzheimer's treatment methods is a significant milestone for Cyclo Therapeutics. This development could enhance the company's intellectual property portfolio and potentially lead to future revenue streams. The news is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100